Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer

1. Sonnenblick, A.
2. Francis, P.A.
3. Azim, H.A.
4. De Azambuja, E.
5. Nordenskjöld, B.
6. Gutiérez, J.
7. Quinaux, E.
8. Mastropasqua, M.G.
9. Ameye, L.
10. Anderson, M.
11. Lluch, A.
12. Gnant, M.
13. Goldhirsch, A.
14. Di Leo, A.
15. Barnadas, A.
16. Cortes-Funes, H.
17. Piccart, M.
18. Crown, J.